(Q28287913)

2

0 references

Harmeet Sidhu

3

0 references

Ruth Hönow

4

0 references

Gerd von Unruh

5

0 references

Albrecht Hesse

Current aspects of epidemiology and nutrition in urinary stone disease

6

0 references

language of work or name

English

0 references

publication date

June 2013

0 references

published in

Kidney International

0 references

volume

83

0 references

issue

6

0 references

page(s)

1144-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Contribution of dietary oxalate to urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalate contents of species of the Polygonaceae, Amaranthaceae and Chenopodiaceae families

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalate content of cereals and cereal products

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalate content of green tea of different origin, quality, preparation and time of harvest

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalobacter formigenes and its potential role in human health.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Urinary Oxalate Levels and the Enteric Bacterium Oxalobacter formigenes in Patients with Calcium Oxalate Urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Probiotics and other key determinants of dietary oxalate absorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Interference-free sample preparation for the determination of plasma oxalate analyzed by HPLC-ER: preliminary results from calcium oxalate stone-formers and non-stone-formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Hyperoxaluria: a gut-kidney axis?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.104

7 January 2021